ZTS Zoetis PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ZTS
- PE Ratio
As of Aug 8, 2025, the Zoetis stock's price-to-earnings ratio is 25.32. This results from the current EPS of $5.82 and stock price of $147.35. The PE ratio has decreased by 17% from the past four quarters average of 30.7.
ZTS PE ratio history
The PE ratio of Zoetis has averaged 39.39 over the last ten years. The current P/E ratio of 25.32 is 36% lower than the historical average. In the past ten years, ZTS's PE ratio peaked in the Dec 2015 quarter at 70.47, when the stock price was $47.92 and the EPS was $0.68. The lowest point was in the Jun 2025 quarter, when it reached 26.8 with a price of $155.95 and an EPS of $5.82.
Zoetis PE ratio by year
Maximum annual increase: 90% in 2015
Maximum annual decrease: -54.24% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 29.79 | -23.32% | $162.93 | $5.47 |
| 2023 | 38.85 | 19.58% | $197.37 | $5.08 |
| 2022 | 32.49 | -42.88% | $146.55 | $4.51 |
| 2021 | 56.88 | 18.23% | $244.03 | $4.29 |
| 2020 | 48.11 | 14.14% | $165.5 | $3.44 |
| 2019 | 42.15 | 45.85% | $132.35 | $3.14 |
| 2018 | 28.9 | -29.39% | $85.54 | $2.96 |
| 2017 | 40.93 | 26.91% | $72.04 | $1.76 |
| 2016 | 32.25 | -54.24% | $53.53 | $1.66 |
| 2015 | 70.47 | 90% | $47.92 | $0.68 |
| 2014 | 37.09 | 14.58% | $43.03 | $1.16 |
| 2013 | 32.37 | N/A | $32.69 | $1.01 |
| 2012 | N/A | N/A | N/A | $0.87 |
| 2011 | N/A | N/A | N/A | $0.49 |
| 2010 | N/A | N/A | N/A | $0.22 |
Zoetis PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 26.8 | -9.18% | $155.95 | $5.82 |
| Mar 2025 | 29.51 | -0.94% | $164.65 | $5.58 |
| Dec 2024 | 29.79 | -18.74% | $162.93 | $5.47 |
| Sep 2024 | 36.66 | 8.05% | $195.38 | $5.33 |
| Jun 2024 | 33.93 | 4.08% | $173.36 | $5.11 |
| Mar 2024 | 32.6 | -16.09% | $169.21 | $5.19 |
| Dec 2023 | 38.85 | 9.87% | $197.37 | $5.08 |
| Sep 2023 | 35.36 | -2.27% | $173.98 | $4.92 |
| Jun 2023 | 36.18 | -3.49% | $172.21 | $4.76 |
| Mar 2023 | 37.49 | 15.39% | $166.44 | $4.44 |
| Dec 2022 | 32.49 | -3.82% | $146.55 | $4.51 |
| Sep 2022 | 33.78 | -13.14% | $148.29 | $4.39 |
| Jun 2022 | 38.89 | -9.89% | $171.89 | $4.42 |
| Mar 2022 | 43.16 | -24.12% | $188.59 | $4.37 |
| Dec 2021 | 56.88 | 22.16% | $244.03 | $4.29 |
ZTS Price vs fair value
ZTS average PE ratio chart
The current PE ratio of ZTS is lower than the 3, 5 and 10-year averages.
ZTS PE vs peers
In comparison to its peers LLY and PAHC, ZTS's PE ratio is lower, but it is higher than MRK's and PFE's. Zoetis's current PE ratio of 25.32 is similar to the average of its peer group, which is 25.44.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 12.41 | $201.55B |
| PFE Pfizer Inc | 13.01 | $139.75B |
| ZTS Zoetis Inc | 25.32 | $65.3B |
| PAHC Phibro Animal Health Corp | 35.57 | $1.14B |
| LLY ELI LILLY & Co | 40.76 | $592.15B |
| ICCC Immucell Corp | N/A | $60.19M |
Frequently asked questions
What is Zoetis's PE ratio?
ZTS stock has a price to earnings ratio of 25.32 as of Aug 8, 2025.
What is the 3-year average PE ratio for Zoetis (ZTS)?
The 3-year average price to earnings ratio for ZTS stock is 33.62.
What is the 5-year average PE ratio for Zoetis (ZTS)?
The 5-year average price to earnings ratio for ZTS stock is 38.64.
What is the highest PE ratio for ZTS?
The highest quarterly PE ratio in the last ten years has been 70.47 and it was in the Dec 2015 quarter.
How does the current PE ratio for ZTS compare to its historical average?
ZTS's price to earnings ratio is currently 36% below its 10-year historical average.
How is ZTS's PE ratio calculated (Zoetis PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Aug 8, 2025), Zoetis's stock price is $147.35. The earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $5.82. Therefore, Zoetis's PE ratio for today is 25.32. PE RATIO(25.32) = STOCK PRICE($147.35) / TTM EPS($5.82)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.